◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksTECH › EBITDA

Bio-Techne Corp (TECH) EBITDA 2006–TTM

DATA UPDATED 2026-07-19

Bio-Techne Corp annual ebitda for fiscal TTM was $258 million, an increase of 18.9% from $217 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

TECH Annual EBITDA

EBITDA (annual)TTM → 2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
EBITDA$258M$217M$313M$457M$414M$250M$378M$212M$201M$182M$193M$184M$179M$173M$175M$174M$165M$159M$152M$137M$115M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TECH Quarterly EBITDA

EBITDA (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
EBITDA$99M$78M$75M$6M$68M$72M$70M$72M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More TECH metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All TECH financial statements → Interactive TECH charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.